Canada markets close in 2 hours 39 minutes

Fulcrum Therapeutics, Inc. (FULC)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
7.70-0.05 (-0.65%)
As of 01:20PM EDT. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) 481.69M
Enterprise Value 256.29M
Trailing P/E 315.25
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)169.39
Price/Book (mrq)2.05
Enterprise Value/Revenue 91.37
Enterprise Value/EBITDA -2.36

Trading Information

Stock Price History

Beta (5Y Monthly) 2.28
52-Week Change 3148.38%
S&P500 52-Week Change 322.38%
52 Week High 313.70
52 Week Low 32.65
50-Day Moving Average 39.13
200-Day Moving Average 36.23

Share Statistics

Avg Vol (3 month) 3628.17k
Avg Vol (10 day) 3413.8k
Shares Outstanding 562.15M
Implied Shares Outstanding 662.15M
Float 838.55M
% Held by Insiders 11.40%
% Held by Institutions 199.51%
Shares Short (Apr 15, 2024) 42.53M
Short Ratio (Apr 15, 2024) 44.35
Short % of Float (Apr 15, 2024) 45.08%
Short % of Shares Outstanding (Apr 15, 2024) 44.08%
Shares Short (prior month Mar 15, 2024) 42.39M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-3,213.78%

Management Effectiveness

Return on Assets (ttm)-28.56%
Return on Equity (ttm)-44.84%

Income Statement

Revenue (ttm)2.81M
Revenue Per Share (ttm)0.05
Quarterly Revenue Growth (yoy)27.20%
Gross Profit (ttm)N/A
EBITDA -108.49M
Net Income Avi to Common (ttm)-97.33M
Diluted EPS (ttm)-1.59
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)236.22M
Total Cash Per Share (mrq)3.81
Total Debt (mrq)10.82M
Total Debt/Equity (mrq)4.60%
Current Ratio (mrq)17.71
Book Value Per Share (mrq)3.80

Cash Flow Statement

Operating Cash Flow (ttm)-90.97M
Levered Free Cash Flow (ttm)-56.72M